Corsair Capital Management, L.P. Renovo Rx, Inc. Transaction History
Corsair Capital Management, L.P.
- $377 Million
- Q1 2025
A detailed history of Corsair Capital Management, L.P. transactions in Renovo Rx, Inc. stock. As of the latest transaction made, Corsair Capital Management, L.P. holds 187,700 shares of RNXT stock, worth $221,486. This represents 0.05% of its overall portfolio holdings.
Number of Shares
187,700
Previous 187,700
-0.0%
Holding current value
$221,486
Previous $185,000
-0.0%
% of portfolio
0.05%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding RNXT
# of Institutions
29Shares Held
11MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD3.47MShares$4.09 Million1.85% of portfolio
-
Awm Investment Company, Inc. New York, NY2.29MShares$2.7 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.35MShares$1.59 Million0.0% of portfolio
-
Bank Of The West975KShares$1.15 Million0.27% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL689KShares$812,5200.0% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $10.7M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...